Emergent BioSolutions (EBS) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.29 +1.34%
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $120.45 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- ExxonMobil outlines key factors for Q2 2026 earnings outlook
- Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
